6C4C.21

ICD-11 MMS 2026-01

MDMA or related drug dependence, including MDA, early full remission

Description

After a diagnosis of MDMA or related drug dependence, including MDA, and often following a treatment episode or other intervention (including self-help intervention), the individual has been abstinent from MDMA or related drug dependence, including MDA, during a period lasting from between 1 and 12 months.

Index terms

  • MDMA or related drug dependence, including MDA, early full remission
  • Ecstasy or related drug dependence, early full remission

Excludes

  • 6C4C.0 – Episode of harmful use of MDMA or related drugs, including MDA
  • 6C4C.1 – Harmful pattern of use of MDMA or related drugs, including MDA

Exclusions from above levels

  • QE11.6 – Hazardous use of MDMA or related drugs
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C4C.20 – MDMA or related drug dependence, including MDA, current use
  • 6C4C.22 – MDMA or related drug dependence, including MDA, sustained partial remission
  • 6C4C.23 – MDMA or related drug dependence, including MDA, sustained full remission
  • 6C4C.2Z – MDMA or related drug dependence, including MDA, unspecified

Foundation entity

MDMA or related drug dependence, including MDA, early full remission – http://id.who.int/icd/entity/203295904

Allowed postcoordination axes

Part of: 6C4C.2: MDMA or related drug dependence, including MDA › 6C4C: Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] › 06: Mental, behavioural or neurodevelopmental disorders